# Study in Healthy Males to Assess Bioavailability of Single Fostamatinib With iv Micro Tracer Dose

> **NCT01598571** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 37 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Fostamatinib
- **DRUG:** Fostamatinib

## Key facts

- **NCT ID:** NCT01598571
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2012-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01598571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01598571, "Study in Healthy Males to Assess Bioavailability of Single Fostamatinib With iv Micro Tracer Dose". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT01598571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*